logo
Select company
Select metric
$ -7.44EBIT per Share
VS
Market
4
Sector
9
Industry
11
History
93
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information

Ticker

ERNA

Company Name

ERNEXA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ERNEXA THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ERNA - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -38.51M$ -7.4415.18M
3/31/2025$ -40.1M$ -11.2713.56M
12/31/2024$ -37.76M$ -41.51909.8K
9/30/2024$ -41.03M$ -113.781360.67K
6/30/2024$ -21.73M$ -60.241360.67K
3/31/2024$ -21.5M$ -59.621360.67K
12/31/2023$ -21.06M$ -59.441354.27K
9/30/2023$ -19.96M$ -55.351360.67K
6/30/2023$ -21.68M$ -61.311353.53K
3/31/2023$ -20.57M$ -60.181341.8K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -1.18K.
  • Over the past 5 years, ERNEXA THERAPEUTICS INC's average EBITPS has been $ -299.67.
  • The median EBITPS for ERNEXA THERAPEUTICS INC during this period was $ -117.2
  • ERNEXA THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -7.44.
  • The lowest EBITPS recorded by ERNEXA THERAPEUTICS INC in the same timeframe $ -1.18K

ERNEXA THERAPEUTICS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
BRTX : BIORESTORATIVE THERAPIES INC $ -1.23VYNE : VYNE THERAPEUTICS INC $ -0.9IBIO : IBIO INC $ -1.73LEXX : LEXARIA BIOSCIENCE CORP $ -0.62LYRA : LYRA THERAPEUTICS INC $ -28.78PULM : PULMATRIX INC $ -2.17APRE : APREA THERAPEUTICS INC $ -2.44HCWB : HCW BIOLOGICS INC $ -5.87MGRX : MANGOCEUTICALS INC $ -1.44PHIO : PHIO PHARMACEUTICALS CORP $ -1.48

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for ERNEXA THERAPEUTICS INC is calculated as follows: EBIT [ $ -5.79M ] / (Shares WA [ 4.89K ] * Share Factor [ 1 ])
(=) EBITPS [ $ -1.18K ]

ERNA - EBIT per Share, Last 5 years

$ -1.18K

Minimum

Sep 30, 2020

$ -7.44

Maximum

Jun 30, 2025

$ -299.67

Average

$ -117.2

Median

EBITPS Benchmark Analysis

The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.17 with a standard deviation of $ 3.44.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.8K
min$ -9.77
max$ 10.86
average$ 1.17
median$ 0.39
std$ 3.44